SANUWAVE Health, Inc. Common Stock
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more
SANUWAVE Health, Inc. Common Stock (SNWV) - Net Assets
Latest net assets as of September 2025: $-2.93 Million USD
Based on the latest financial reports, SANUWAVE Health, Inc. Common Stock (SNWV) has net assets worth $-2.93 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($35.60 Million) and total liabilities ($38.53 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.93 Million |
| % of Total Assets | -8.23% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SANUWAVE Health, Inc. Common Stock - Net Assets Trend (2006–2024)
This chart illustrates how SANUWAVE Health, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SANUWAVE Health, Inc. Common Stock (2006–2024)
The table below shows the annual net assets of SANUWAVE Health, Inc. Common Stock from 2006 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-12.72 Million | +70.55% |
| 2023-12-31 | $-43.18 Million | -5.29% |
| 2022-12-31 | $-41.01 Million | -5.27% |
| 2021-12-31 | $-38.96 Million | -183.97% |
| 2020-12-31 | $-13.72 Million | -36.32% |
| 2019-12-31 | $-10.06 Million | +34.47% |
| 2018-12-31 | $-15.36 Million | -55.41% |
| 2017-12-31 | $-9.88 Million | -42.96% |
| 2016-12-31 | $-6.91 Million | -17.59% |
| 2015-12-31 | $-5.88 Million | -278.87% |
| 2014-12-31 | $-1.55 Million | +74.68% |
| 2013-12-31 | $-6.13 Million | +6.00% |
| 2012-12-31 | $-6.52 Million | -324.28% |
| 2011-12-31 | $-1.54 Million | +85.39% |
| 2010-12-31 | $-10.52 Million | -78.72% |
| 2009-12-31 | $-5.88 Million | -7963.91% |
| 2008-12-31 | $-72.97K | -57.19% |
| 2007-12-31 | $-46.42K | -332.67% |
| 2006-12-31 | $-10.73K | -- |
Equity Component Analysis
This analysis shows how different components contribute to SANUWAVE Health, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 633753.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $238.70 Million | % |
| Total Equity | $-12.72 Million | 100.00% |
SANUWAVE Health, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of SANUWAVE Health, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jiangsu Xinri E-Vehicle Co Ltd
SHG:603787
|
$150.33 Million |
|
Is Finansal Kiralama AS
IS:ISFIN
|
$150.35 Million |
|
Gencor Industries Inc
NYSE MKT:GENC
|
$150.36 Million |
|
Izmir Firca Sanayi ve Ticaret
IS:IZFAS
|
$150.37 Million |
|
Nanning Sugar Industry Co Ltd
SHE:000911
|
$150.30 Million |
|
Titomic Ltd
AU:TTT
|
$150.27 Million |
|
SatixFy Communications Ltd
NYSE MKT:SATX
|
$150.25 Million |
|
Premier Miton Group plc
PINK:PASMF
|
$150.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SANUWAVE Health, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -43,178,000 to -12,717,000, a change of 30,461,000.
- Net loss of 31,372,000 reduced equity.
- New share issuances of 10,300,000 increased equity.
- Other comprehensive income increased equity by 111,000.
- Other factors increased equity by 51,422,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-31.37 Million | -246.69% |
| Share Issuances | $10.30 Million | +80.99% |
| Other Comprehensive Income | $111.00K | +0.87% |
| Other Changes | $51.42 Million | +404.36% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares SANUWAVE Health, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | $0.00 | $30.67 | x |
| 2007-12-31 | $0.00 | $30.67 | x |
| 2008-12-31 | $-0.01 | $30.67 | x |
| 2009-12-31 | $-0.52 | $30.67 | x |
| 2010-12-31 | $-0.81 | $30.67 | x |
| 2011-12-31 | $-0.08 | $30.67 | x |
| 2012-12-31 | $-0.31 | $30.67 | x |
| 2013-12-31 | $-0.22 | $30.67 | x |
| 2014-12-31 | $-0.03 | $30.67 | x |
| 2015-12-31 | $-0.09 | $30.67 | x |
| 2016-12-31 | $-0.06 | $30.67 | x |
| 2017-12-31 | $-0.07 | $30.67 | x |
| 2018-12-31 | $-0.10 | $30.67 | x |
| 2019-12-31 | $-0.05 | $30.67 | x |
| 2020-12-31 | $-0.03 | $30.67 | x |
| 2021-12-31 | $-0.08 | $30.67 | x |
| 2022-12-31 | $-0.07 | $30.67 | x |
| 2023-12-31 | $-0.05 | $30.67 | x |
| 2024-12-31 | $-1.49 | $30.67 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SANUWAVE Health, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -96.13%
- • Asset Turnover: 1.08x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 0.00% | 0.00% | 0.00x | 0.00x | $23.06K |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-31.05K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.25K |
| 2009 | 0.00% | -931.26% | 0.11x | 0.00x | $-5.56 Million |
| 2010 | 0.00% | -2048.53% | 0.24x | 0.00x | $-13.87 Million |
| 2011 | 0.00% | -1275.75% | 0.13x | 0.00x | $-10.09 Million |
| 2012 | 0.00% | -832.21% | 0.42x | 0.00x | $-5.75 Million |
| 2013 | 0.00% | -1412.41% | 0.50x | 0.00x | $-10.69 Million |
| 2014 | 0.00% | -705.02% | 0.18x | 0.00x | $-5.82 Million |
| 2015 | 0.00% | -498.22% | 1.01x | 0.00x | $-4.22 Million |
| 2016 | 0.00% | -467.93% | 1.37x | 0.00x | $-5.75 Million |
| 2017 | 0.00% | -749.86% | 0.58x | 0.00x | $-4.55 Million |
| 2018 | 0.00% | -628.70% | 1.57x | 0.00x | $-10.10 Million |
| 2019 | 0.00% | -1192.35% | 0.30x | 0.00x | $-11.26 Million |
| 2020 | 0.00% | -762.47% | 0.18x | 0.00x | $-29.57 Million |
| 2021 | 0.00% | -209.52% | 0.70x | 0.00x | $-23.36 Million |
| 2022 | 0.00% | -61.48% | 0.84x | 0.00x | $-6.19 Million |
| 2023 | 0.00% | -126.52% | 0.91x | 0.00x | $-21.49 Million |
| 2024 | 0.00% | -96.13% | 1.08x | 0.00x | $-30.10 Million |
Industry Comparison
This section compares SANUWAVE Health, Inc. Common Stock's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SANUWAVE Health, Inc. Common Stock (SNWV) | $-2.93 Million | 0.00% | N/A | $150.30 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |